van der Leeuw J, Visseren F, Woodward M, Zoungas S, Kengne A, van der Graaf Y, et al. Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation. Hypertension. 2015;65:115-21 pubmed publisher

Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med. 2014;371:1392-406 pubmed publisher

Kristensen K, Zhu H, Wang X, Gislason G, Torp Pedersen C, Rasmussen H, et al. Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: a proof-of-concept study. Clin Pharmacol Ther. 2014;96:713-22 pubmed publisher

Nishimuta H, Houston J, Galetin A. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs. Drug Metab Dispos. 2014;42:1522-31 pubmed publisher

Leloup A, Fransen P, Van Hove C, Demolder M, De Keulenaer G, Schrijvers D. Applanation tonometry in mice: a novel noninvasive technique to assess pulse wave velocity and arterial stiffness. Hypertension. 2014;64:195-200 pubmed publisher

Xiong F, Zhao J, Zeng G, Huang B, Yuan D, Yang Y. Inhibition of AAA in a rat model by treatment with ACEI perindopril. J Surg Res. 2014;189:166-73 pubmed publisher

Carradice D, Maxwell E. Inadvertent dispensing of Coumadin instead of Coversyl. Med J Aust. 2013;199:750 pubmed

Yamout H, Bakris G. Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus. Hypertension. 2014;63:220-1 pubmed publisher

Chalmers J, Arima H, Woodward M, Mancia G, Poulter N, Hirakawa Y, et al. Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial. Hypertension. 2014;63:259-64 pubmed publisher

Westra I, Oosterhuis D, Groothuis G, Olinga P. Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs. Toxicol Appl Pharmacol. 2014;274:328-38 pubmed publisher

Barron A, Hughes A, Sharp A, Baksi A, Surendran P, Jabbour R, et al. Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy. Hypertension. 2014;63:252-8 pubmed publisher

Gumustas M, Ozkan S. A validated stability-indicating RP-LC method for the simultaneous determination of amlodipine and perindopril in tablet dosage form and their stress degradation behavior under ICH-recommended stress conditions. J AOAC Int. 2013;96:751-7 pubmed

Zueva M, Tsapenko I, Riabina M, Okhomtsimskaia T, Grinchenko M. [Changes of retinal neurons and Muller glial cells in patients with type II diabetes in treatment of diabetic retinopathy with angiotensin-converting enzyme inhibitor]. Vestn Oftalmol. 2013;129:44-7 pubmed

Iskenderov B, Budagovskaya Z, Sisina O. [Effect of a fixed-dose perindopril and amlodipine combination on intrarenal hemodynamic and kidney functional parameters in patients with essential hypertension]. Ter Arkh. 2013;85:78-83 pubmed

Bulpitt C, Beckett N, Peters R, Staessen J. Response to HYVET ambulatory blood pressure substudy. Hypertension. 2013;61:e43 pubmed

Battes L, Barendse R, Steyerberg E, Simoons M, Deckers J, Nieboer D, et al. Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease. Am J Cardiol. 2013;112:27-33 pubmed publisher

Karpov I. [The FORTISSIMO program: advantages of fixed full dose combination of perindopril arginine and indapamide in the treatment of poorly controlled arterial hypertension]. Kardiologiia. 2013;53:37-43 pubmed

Ben Dov I, Bursztyn M. HYVET ambulatory blood pressure substudy. Hypertension. 2013;61:e42 pubmed publisher

Murphy K, Chee A, Trieu J, Naim T, Lynch G. Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia. Int J Cancer. 2013;133:1234-46 pubmed publisher

Zhang Y, Ly C, Yannoutsos A, Agnoletti D, Mourad J, Safar M, et al. Effect of a fixed combination of Perindopril and Amlodipine on blood pressure control in 6256 patients with not-at-goal hypertension: the AVANT'AGE study. J Am Soc Hypertens. 2013;7:163-9 pubmed publisher

Krysiak R, Okopień B. Different effects of perindopril and enalapril on monocyte cytokine release in coronary artery disease patients with normal blood pressure. Pharmacol Rep. 2012;64:1466-75 pubmed

Spence J. Asymptomatic carotid stenosis. Circulation. 2013;127:739-42 pubmed publisher

Liang J, Bai S, Xu D, Cheng Z. [Effect of different doses of perindopril on myocardial energy expenditure in patients with heart failure following myocardial infarction]. Nan Fang Yi Ke Da Xue Xue Bao. 2012;32:1816-9, 1832 pubmed

Napalkov D. [Therapy with perindopril: organoprotection, not just the antihypertensive effect]. Kardiologiia. 2012;52:80-3 pubmed

Tikellis C, Pickering R, Tsorotes D, Harjutsalo V, Thorn L, Ahola A, et al. Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes. Clin Sci (Lond). 2013;124:617-26 pubmed publisher

Shevelev V, Kanorskii S. [Antihypertensive therapy and dynamics of vascular wall rigidity in elderly patients with non-valvular atrial fibrillation]. Klin Med (Mosk). 2012;90:59-63 pubmed

Grabowski T, Jaroszewski J, Sasinowska Motyl M. Leave-one-out procedure in the validation of elimination rate constant analysis. Arzneimittelforschung. 2012;62:682-9 pubmed publisher

Bulpitt C, Beckett N, Peters R, Staessen J, Wang J, Comsa M, et al. Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project. Hypertension. 2013;61:89-94 pubmed publisher

Protasov K, Sinkevich D, Reshina I, Zhizhko N, Logovikova S, Golubeva L. [Vascular effects of perindopril arginine and indapamide fixed combination in patients with arterial hypertension]. Kardiologiia. 2012;52:8-14 pubmed

Khovaeva I, Golovskoĭ B, Batalova A, Burdina E, Korovin A, Matveeva A. [Time course of changes in brachial artery function in patients with unstable angina pectoris during perindopril therapy]. Ter Arkh. 2012;84:30-4 pubmed

Millot I, Plancade D, Hosotte M, Landy C, Nadaud J, Ragot C, et al. Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates. Br J Anaesth. 2012;109:827-9 pubmed publisher

Wagner L, Fekete A, Rudolf A, Doros A, Langer R. The safe introduction of angiotensin-converting enzyme inhibitor in renal allograft recipients. Transplant Proc. 2012;44:2151-3 pubmed publisher

Osuch E, Du Plooy W, Du Plooy S, Böhmer L. Effect of perindopril on pulse-wave velocity and endothelin-1 in black hypertensive patients. Cardiovasc J Afr. 2012;23:396-9 pubmed publisher

Peters R, Beckett N, Poulter R, Burch L, Narkiewicz K, Fagard R, et al. Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial. Age Ageing. 2013;42:253-8 pubmed publisher

Hussein Al Ali S, Al Qubaisi M, Hussein M, Ismail M, Zainal Z, Hakim M. Comparative study of Mg/Al- and Zn/Al-layered double hydroxide-perindopril erbumine nanocomposites for inhibition of angiotensin-converting enzyme. Int J Nanomedicine. 2012;7:4251-62 pubmed publisher

Mukhtar O, Jackson S. The Hypertension in the Very Elderly Trial - latest data. Br J Clin Pharmacol. 2013;75:951-4 pubmed publisher

Hatala R, Pella D, Hatalová K, Sidlo R. Optimization of blood pressure treatment with fixed-combination perindopril/amlodipine in patients with arterial hypertension. Clin Drug Investig. 2012;32:603-12 pubmed publisher

Belenkov I, Privalova E, Danilogorskaia I, Zheleznykh E, Shchendrygina A. [Remodeling of vascular bed in patients with arterial hypertension: possibilities of diagnostics and correction]. Kardiologiia. 2012;52:67-72 pubmed

Kaski J, Consuegra Sanchez L. PERTINENT (a substudy of the EUROPA trial): a persistent legacy. Cardiovasc Res. 2012;96:202-3; discussion 204-7 pubmed publisher

Karpov I, Deev A. [Uncontrolled arterial hypertension--new possibilities in solving problems of increasing the effectiveness of treatment]. Kardiologiia. 2012;52:29-35 pubmed

Nia A, Er F. Angioedema associated with the use of angiotensin-converting enzyme inhibitor. CMAJ. 2013;185:E80 pubmed publisher